660048 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer |
2021-03-01 |
10.1136/jitc-2020-001556 |
Madan Ravi A, Karzai Fatima, Donahue Renee N, Al-Harthy Munjid, Bilusic Marijo, Rosner Inger I, Singh Harpreet, Arlen Philip M, Theoret Marc R, Marté Jennifer L, Cordes Lisa, Couvillon Anna, Hankin Amy, Williams Moniquea, Owens Helen, Lochrin Sarah E, Chau Cindy H, Steinberg Seth, Figg William Douglas, Dahut William, Schlom Jeffrey, Gulley James L |
660047 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells |
2021-03-01 |
10.1136/jitc-2020-002138 |
Sun Yi, Jing Jun, Xu Huan, Xu Lingfan, Hu Hailiang, Tang Cai, Liu Shengzhuo, Wei Qiang, Duan Ruiqi, Guo Ju, Yang Lu |
660046 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation |
2021-03-01 |
10.1136/jitc-2020-001496 |
Redin Esther, Garmendia Irati, Lozano Teresa, Serrano Diego, Senent Yaiza, Redrado Miriam, Villalba Maria, De Andrea Carlos E, Exposito Francisco, Ajona Daniel, Ortiz-Espinosa Sergio, Remirez Ana, Bertolo Cristina, Sainz Cristina, Garcia-Pedrero Juana, Pio Ruben, Lasarte Juan, Agorreta Jackeline, Montuenga Luis M, Calvo Alfonso |
660045 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors |
2021-03-01 |
10.1136/jitc-2020-001948 |
Karaki Soumaya, Blanc Charlotte, Tran Thi, Galy-Fauroux Isabelle, Mougel Alice, Dransart Estelle, Anson Marie, Tanchot Corinne, Paolini Lea, Gruel Nadege, Gibault Laure, Lepimpec-Barhes Francoise, Fabre Elizabeth, Benhamouda Nadine, Badoual Cecile, Damotte Diane, Donnadieu Emmanuel, Kobold Sebastian, Mami-Chouaib Fathia, Golub Rachel, Johannes Ludger, Tartour Eric |
660044 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer |
2021-03-01 |
10.1136/jitc-2020-001610 |
Seo Incheol, Lee Hye Won, Byun Sang Jun, Park Jee Young, Min Hyeonji, Lee Sung Hwan, Lee Ju-Seog, Kim Shin, Bae Sung Uk |
660043 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3 |
2021-03-01 |
10.1136/jitc-2020-001946 |
Zhou Zhengjun, Wang Pengcheng, Sun Rongqi, Li Jia, Hu Zhiqiang, Xin Haoyang, Luo Chubin, Zhou Jian, Fan Jia, Zhou Shaolai |
660042 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy |
2021-03-01 |
10.1136/jitc-2020-001764 |
Olivo Pimentel Veronica, Marcus Damiënne, van der Wiel Alexander MA, Lieuwes Natasja G, Biemans Rianne, Lieverse Relinde IY, Neri Dario, Theys Jan, Yaromina Ala, Dubois Ludwig J, Lambin Philippe |
660041 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Perspectives on COVID-19 and cancer immunotherapy: a review series |
2021-03-01 |
10.1136/jitc-2021-002489 |
Goldman Jason D, Ascierto Paolo Antonio |
660040 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis |
2021-03-01 |
10.1136/jitc-2020-002058corr1 |
|
660039 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells |
2021-03-01 |
10.1136/jitc-2020-002128 |
Lee Maxwell Y, Robbins Yvette, Sievers Cem, Friedman Jay, Abdul Sater Houssein, Clavijo Paul E, Judd Nancy, Tsong Edward, Silvin Chris, Soon-Shiong Patrick, Padget Michelle R, Schlom Jeffrey, Hodge James, Hinrichs Christian, Allen Clint |